Interferon Beta-1a treatment promotes SARS-CoV-2 mRNA vaccine response in multiple sclerosis subjects
Giorgia Teresa Maniscalco, Valentino Manzo, Anne Lise Ferrara, Alessandro Perrella, Mariaelena Di Battista, Simona Salvatore, Daniela Graziano, Assunta Viola, Gerardino Amato, Ornella Moreggia, Daniele Di Giulio Cesare, Stefano Barbato, Giovanna Servillo, Katia Longo, Mario Di Giovanni, Barbara Scarpati, Simona Maria Muggianu, Giuseppe Longo, Giuseppe Russo, Vincenzo Andreone, Veronica De Rosa
Topics & Concepts
Multiple sclerosisMedicineInterferon betaSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyCoronavirus disease 2019 (COVID-19)ImmunologyInterferon2019-20 coronavirus outbreakBETA (programming language)Interferon beta-1bAntibody responseAntibodyInternal medicineDiseaseInfectious disease (medical specialty)OutbreakProgramming languageComputer scienceSARS-CoV-2 and COVID-19 ResearchMultiple Sclerosis Research Studiesvaccines and immunoinformatics approaches